{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:07:20Z","timestamp":1793390840586,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-025-03983-x","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:57:45Z","timestamp":1758740265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The relationship of antimullerian hormone with severity of clinical symptoms in polycystic ovary syndrome"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0841-0480","authenticated-orcid":false,"given":"Can","family":"Ata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2109-1373","authenticated-orcid":false,"given":"Ufuk","family":"Atlihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0636-3104","authenticated-orcid":false,"given":"Huseyin Aytug","family":"Avsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3716-2145","authenticated-orcid":false,"given":"Onur","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6512-9070","authenticated-orcid":false,"given":"Selcuk","family":"Erkilinc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6432-6777","authenticated-orcid":false,"given":"Tevfik Berk","family":"Bildaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"issue":"6","key":"3983_CR1","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745\u20139.","journal-title":"J Clin Endocrinol Metab."},{"key":"3983_CR2","doi-asserted-by":"crossref","unstructured":"Chang J, Azziz\u00a0R, Legro R, Dewailly D, Franks S, Tarlatzis R, et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"issue":"6","key":"3983_CR3","first-page":"774","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774\u2013800.","journal-title":"Endocr Rev."},{"issue":"5","key":"3983_CR4","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/humupd\/dmu012","volume":"20","author":"JA Barry","year":"2014","unstructured":"Barry JA, Azizia MM, Hardiman PJ. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(5):748\u201358.","journal-title":"Hum Reprod Update."},{"issue":"11","key":"3983_CR5","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1093\/humrep\/der297","volume":"26","author":"D Dewailly","year":"2011","unstructured":"Dewailly D, Gronier H, Poncelet E, Robin G, Leroy M, Pigny P, et al. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod. 2011;26(11):3123\u20139.","journal-title":"Hum Reprod."},{"issue":"2","key":"3983_CR6","first-page":"90","volume":"13","author":"A Daniilidis","year":"2009","unstructured":"Daniilidis A, Dinas K. Long term health consequences of polycystic ovarian syndrome: a review analysis. Hippokratia. 2009;13(2):90\u20132.","journal-title":"Hippokratia."},{"issue":"1","key":"3983_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ejogrb.2013.05.019","volume":"170","author":"S Sahmay","year":"2013","unstructured":"Sahmay S, Atakul N, Oncul M, Tuten A, Aydogan B, Seyisoglu H. Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):157\u201361.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"1","key":"3983_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/jc.2006-1582","volume":"92","author":"L Pellatt","year":"2007","unstructured":"Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehead S, et al. Granulosa cell production of anti-M\u00fcllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab. 2007;92(1):240\u20135.","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"3983_CR9","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1093\/humrep\/dep210","volume":"24","author":"A La Marca","year":"2009","unstructured":"La Marca A, Broekmans FJ, Volpe A, Fauser BC, Macklon NS. Anti-Mullerian hormone (AMH): what do we still need to know? Hum Reprod. 2009;24(9):2264\u201375.","journal-title":"Hum Reprod."},{"issue":"1","key":"3983_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.fertnstert.2011.04.003","volume":"96","author":"YH Lin","year":"2011","unstructured":"Lin YH, Chiu WC, Wu CH, Tzeng CR, Hsu CS, Hsu MI. Antim\u00fcllerian hormone and polycystic ovary syndrome. Fertil Steril. 2011;96(1):230\u20135.","journal-title":"Fertil Steril."},{"issue":"1","key":"3983_CR11","doi-asserted-by":"publisher","first-page":"77.e1","DOI":"10.1016\/j.ajog.2006.07.046","volume":"196","author":"JG Wang","year":"2007","unstructured":"Wang JG, Nakhuda GS, Guarnaccia MM, Sauer MV, Lobo RA. M\u00fcllerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome. Am J Obstet Gynecol. 2007;196(1):77.e1-5.","journal-title":"Am J Obstet Gynecol."},{"issue":"1","key":"3983_CR12","first-page":"32","volume":"22","author":"S Ozel","year":"2021","unstructured":"Ozel S, Alkan M, Tokmak A, Oksuzoglu A, Kaya M, Aktulay A, et al. Relationship Between Polycystic Ovarian Morphology and Ectopic Pregnancy. J Reprod Infertil. 2021;22(1):32\u20137.","journal-title":"J Reprod Infertil."},{"issue":"2","key":"3983_CR13","doi-asserted-by":"publisher","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","volume":"296","author":"A Piouka","year":"2009","unstructured":"Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab. 2009;296(2):E238-43.","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"5","key":"3983_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1530\/REP-09-0415","volume":"139","author":"L Pellatt","year":"2010","unstructured":"Pellatt L, Rice S, Mason HD. Anti-M\u00fcllerian hormone and polycystic ovary syndrome: a mountain too high? Reproduction. 2010;139(5):825\u201333.","journal-title":"Reproduction."},{"issue":"7","key":"3983_CR15","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1093\/humrep\/dep074","volume":"24","author":"SM Carlsen","year":"2009","unstructured":"Carlsen SM, Vanky E, Fleming R. Anti-M\u00fcllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome. Hum Reprod. 2009;24(7):1732\u20138.","journal-title":"Hum Reprod."},{"issue":"5","key":"3983_CR16","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1093\/humrep\/deq028","volume":"25","author":"X Chen","year":"2010","unstructured":"Chen X, Ni R, Mo Y, Li L, Yang D. Appropriate BMI levels for PCOS patients in Southern China. Hum Reprod. 2010;25(5):1295\u2013302.","journal-title":"Hum Reprod."},{"issue":"1","key":"3983_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13048-024-01436-x","volume":"17","author":"MZ Md Muslim","year":"2024","unstructured":"Md Muslim MZ, Mohammed Jelani A, Shafii N, Yaacob NM, Che Soh NAA, Ibrahim HA. Correlation between anti-mullerian hormone with insulin resistance in polycystic ovarian syndrome: a systematic review and meta-analysis. J Ovarian Res. 2024;17(1):106.","journal-title":"J Ovarian Res."},{"key":"3983_CR18","doi-asserted-by":"publisher","first-page":"376","DOI":"10.38053\/acmj.1323489","volume":"5","author":"M Onal","year":"2023","unstructured":"Onal M, Cali H. Anti-M\u00fcllerian hormone and HOMA-IR in different phenotypes of polycystic ovary syndrome on insulin resistance. Anatolian Current Medical Journal. 2023;5:376\u201382.","journal-title":"Anatolian Current Medical Journal."},{"issue":"1","key":"3983_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.fertnstert.2012.03.059","volume":"98","author":"RL Rosenfield","year":"2012","unstructured":"Rosenfield RL, Wroblewski K, Padmanabhan V, Littlejohn E, Mortensen M, Ehrmann DA. Antim\u00fcllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril. 2012;98(1):242\u20139.","journal-title":"Fertil Steril."},{"issue":"10","key":"3983_CR20","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s10815-012-9839-2","volume":"29","author":"Y Li","year":"2012","unstructured":"Li Y, Ma Y, Chen X, Wang W, Li Y, Zhang Q, et al. Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism. J Assist Reprod Genet. 2012;29(10):1147\u201351.","journal-title":"J Assist Reprod Genet."},{"issue":"4","key":"3983_CR21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.fertnstert.2023.12.031","volume":"121","author":"AS Komorowski","year":"2024","unstructured":"Komorowski AS, Hughes L, Sarkar P, Aaby DA, Kumar A, Kalra B, et al. Antim\u00fcllerian hormone level predicts ovulation in women with polycystic ovary syndrome treated with clomiphene and metformin. Fertility and Sterility. 2024;121(4):660\u20138.","journal-title":"Fertility and Sterility."},{"issue":"4","key":"3983_CR22","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/humrep\/den015","volume":"23","author":"MJ Chen","year":"2008","unstructured":"Chen MJ, Yang WS, Chen CL, Wu MY, Yang YS, Ho HN. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome. Hum Reprod. 2008;23(4):952\u20137.","journal-title":"Hum Reprod."}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03983-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-03983-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03983-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:57:47Z","timestamp":1758740267000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-03983-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3983"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-03983-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4592805\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. And this was a retrospective research. All procedures performed were in accordance with the ethical standarts of the institutional committee (Name: Izmir Democracy University, Buca Seyfi Demirsoy Training and Research Hospital Ethics Committee, protocol number 2023\/8-157, Date: 23\/08\/2023).All participiants were consented with informed consents approved by local ethical board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"432"}}